Share on

Global Hemodialysis Catheters Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product (Cuffed Tunneled Catheters, Non-Cuffed Tunneled Catheters and Non-Tunneled Catheters), Tip Configuration (Step-Tip Catheters, Split-Tip Catheters and Symmetric Catheters), Material, End User & Region - Industry Forecasts | 2022 to 2027

Published: January, 2022
ID: 5376
Pages: 175
Formats: report pdf report excel report power bi report ppt

Global Hemodialysis Catheters Market Size (2022 to 2027)

As per our research report, the global hemodialysis catheters market size was worth USD 680.43 Million in 2022 and is forecasted to grow USD 835.83 Million by 2027, registering a CAGR of 4.2% during the forecast period.

Hemodialysis is a medical procedure to remove fluid and waste products from the blood and correct electrolyte imbalances. It is also called an artificial kidney. Hemodialysis is used to treat both acute and chronic kidney failure. Hemodialysis catheters are artificially indwelling transcutaneous conduits used to access the intravascular space or the intraperitoneal space for renal replacement therapy (RRT). There are two types of catheters non – tunneled and tunneled. The non – tunneled catheters are used for short – term extracorporeal renal replacement therapy, it is inserted with the help of ultrasound guidance. 


The growing incidence of ESRD and an increasing number of chronic kidney disorders are majorly expanding the global hemodialysis catheters market growth.

The global hemodialysis catheters market growth is attributed to the increase in the prevalence of end-stage renal diseases (ESRD) and rises in the number of patients suffering from chronic kidney disorders. Also, rising awareness about blood infections is driving the Hemodialysis catheter market globally. The growing number of patients suffering from diabetes and hypertension is more likely to globally fuel the chronic hemodialysis catheter market. In addition, Technological advancements in hemodialysis catheters and dialysis equipment and the rise in demand for hemodialysis amongst chronic kidney disorders further improve the market growth.

Furthermore, the demand is expected to grow due to a lack of available kidney donors for transplantation and technical advancements in dialysis equipment. Hemodialysis catheters are designed to fulfill the health needs of patients undergoing hemodialysis, infusion, apheresis, central venous pressure control, and those receiving high-pressure contrast injections. However, the insertion of intravascular products, especially catheters, is the leading cause of health-care-associated bloodstream infections, which is expected to push the market for hemodialysis catheters. According to many clinical trials, optimal placement of the catheter tip inside the right atrium improves the efficiency and stability of hemodialysis catheters.

In addition, the scarcity of kidney donors raises the need for hemodialysis from CKD patients all over the world. As a result, the demand for hemodialysis catheters grows. According to the American Kidney Fund's kidney disease estimates, more than 31 million people in the United States, or 10% of the adult population, have chronic kidney disease. With age, the chances of developing CKD increase. Rising R&D expenditure for developing new hemodialysis products and the rise in preference for home hemodialysis (HHD) treatment, and increasing investments by government and private organizations encourage market growth.

The death rate due to kidney diseases is increasing across the world. According to WHO, around 10 million people die every year from kidney disease. Changes in lifestyle and rise in several obesity cases, hypertension, and diabetes patients propel the market growth. An increase in the awareness about the benefits of dialysis products is boosting the hemodialysis catheters market growth. There is continuous development in technology related to dialysis. 


Some of the patients experience side effects such as low blood pressure, anemia, muscle cramps, and sleep problem, which is a significant factor hampering the market growth. Lack of proper knowledge over the latest technologies, especially in underdeveloped countries, further impedes market growth.

Shortages hamper the market's development in medical coverage for dialysis procedures in developed countries and a rise in the risk of blood poisoning and thrombosis. Low blood pressure, anemia, muscle cramps, and sleep problems are among the side effects of certain patients, which is a major factor impeding business development. Market growth is further hampered by a lack of proper awareness of the latest technology, especially in developing countries.

Impact of COVID-19 on the global hemodialysis catheters market:

The sudden outbreak of COVID-19 has created an unprecedented loss to the global economy and kept many lives at risk, leading to many people dying across the world. World health organization announced COVID-19 as an emergence to the healthcare sector. The surge in the COVID-19 cases has led to the nationwide lockdown and a ban on transportation to restrict the virus transmission. Manufacturers of chronic hemodialysis catheters, on the other hand, had reduced manufacturing due to global mobility constraints. Also, the disruption in the supply chain has led to the shortage of Hemodialysis catheters. However, the market has gained its momentum after the uplift of the lockdown; this is due to the growing demand for dialysis from patients suffering from chronic kidney disease (CKD) as these patients are at high risks of getting infected with coronavirus due to the compromised immunity, hence, the demand for chronic hemodialysis catheter is expected to increase during the Covid-19 pandemic. 




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Product, Tip Configuration, Material, End User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa


This market research report on the global hemodialysis catheters market has been segmented based on the product, tip configuration, material, end-user, and region.

Hemodialysis Catheters Market - By Product:

  • Cuffed Tunneled Catheters
  • Non-Cuffed Tunneled Catheters
  • Non-tunneled Catheters

Based on the product type, the cuffed tunneled segment is expected to have the largest market share over the analysis period. The growth is due to the growing number of hemodialysis patients. The growing acquisition of tunneled catheters in the hemodialysis process is boosting the market growth.

Hemodialysis Catheters Market - By tip configuration:

  • Step-tip catheters
  • Split-tip catheters
  • Symmetric catheters

Based on the tip configuration analysis, the step-tip catheters segment is estimated to account for the largest market during the forecast period.

Hemodialysis Catheters Market - By Material:

  • Silicone
  • Polyurethane

Based on the material, the polyurethane segment is expected to have the highest growth rate compared with the silicone segment.

Hemodialysis Catheters Market - By End User:

  • Hospitals
  • Clinics
  • Home Dialysis

Based on the end-user, the home dialysis segment is estimated to grow at the highest CAGR rate, showcasing a CAGR of 5.3% from 2019 to 2024. The factors responsible for the growth are user convenience and profits provided by the home dialysis machines.

Hemodialysis Catheters Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, the North American region accounted for the maximum share in the global market in 2019. The U.S. market is currently ruling the global market occupying leading shares. The market in North America is primarily driven by factors such as the well-established healthcare sector, growing awareness about the diseases associated with kidney, improved access to healthcare facilities, and supportive government policies that fuelled the market growth.

The European market has occupied the second largest share of the hemodialysis catheter market due to increasing occurrences of chronic diseases like diabetes, high blood pressure, kidney failure, etc. The market in Europe is expected to grow at a CAGR value of 4.2% over the forecast period.

The Asia Pacific is expected to dominate the market, while Latin America is anticipated to have the fastest growth. Factors like increasing demand for dialysis products and rising awareness are driving these regions. Asia-Pacific has dominated the market that accounts for 5.1% of the hemodialysis catheters market. The growth is due to the accessibility of efficient hemodialysis and favorable reimbursement policies in developing countries such as the U.K. and Germany. Increasing the medical tourism industry is accelerating market growth.

Latin America is to have a steady growth rate over the analysis period due to factors such as the existence of a vast patient pool and growing awareness against the benefits of dialysis. This region provides many opportunities in the dialysis market to surge up the hemodialysis catheters market.

The Middle East & Africa region is expected to grow and expand slowly in the coming years. Also, increasing occurrences of kidney diseases and the increasing number of patient populations suffering from end-stage renal diseases are propelling the market's growth rate. Growing demand for dialysis equipment is also driving the market growth.


Some prominent companies operating in the global hemodialysis catheter market profiled in the report are Fresenius Medical Care AG & Co. KGaA, Nikkiso Co. Ltd, Baxter International Inc., B. Braun Melsungen AG, Nipro Medical Corporation, Toray Medical Co., Ltd., Asahi Kasei Medical Co., Ltd., NxStage Medical, Inc., Outset Medical, Inc, and Allmed Medical Corporation.


  • On June 2, 2020, Citius Pharmaceutical announced that it had received positive feedback from the US Food and Drugs Administration on its proposed catheter compatibility studies for its Mino–Lok therapy.
  • On March 3, 2020, Access Vascular, Inc. announced it had received FDA clearance for the second generation of its HydroPICC peripherally inserted central catheter. Its accumulation rate is 30 times less than traditional PICCSs, and it could reduce catheter occlusions. 
  • On February 13, 2020, CloudCath, a maker of remote monitoring devices for catheter treatment, raised 12 million USD for its new home monitoring devices. 

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample